Cargando…

Interference in point-of-care international normalized ratio monitoring in patients with lupus anticoagulant is correlated with anti–β2-glycoprotein I antibody titers

BACKGROUND: Patients with antiphospholipid syndrome (APS) receive anticoagulant therapy with vitamin K antagonists (VKAs) to prevent recurrent thrombosis. VKA treatment requires strict monitoring with an international normalized ratio (INR). It is known that lupus anticoagulants (LAs) can lead to el...

Descripción completa

Detalles Bibliográficos
Autores principales:	Noordermeer, Tessa, Urbanus, Rolf T., Wong, Chong Y., Jansma, Janna J., Wiersma, Nynke M., Zivkovic, Minka, Huisman, Albert, Limper, Maarten
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2022
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9986099/ https://www.ncbi.nlm.nih.gov/pubmed/36891523 http://dx.doi.org/10.1016/j.rpth.2022.100011

Ejemplares similares

Routine Lupus Anticoagulant Sensitive aPTT Testing Can Prevent Unnecessary LA Testing
por: Smit, Bob, et al.
Publicado: (2023)

Anti‐β2‐glycoprotein I and anti‐prothrombin antibodies cause lupus anticoagulant through different mechanisms of action
por: Noordermeer, Tessa, et al.
Publicado: (2021)

Lupus anticoagulant associates with thrombosis in patients with COVID‐19 admitted to intensive care units: A retrospective cohort study
por: Noordermeer, Tessa, et al.
Publicado: (2022)

DOAC‐Stop in lupus anticoagulant testing: Direct oral anticoagulant interference removed in most samples
por: Baker, Steven Andrew, et al.
Publicado: (2021)

Novel Ex Vivo DOAC Removal Methods Reduce Interference in Lupus Anticoagulant Testing
por: Savola, Paula, et al.
Publicado: (2022)

High titers of myelin oligodendrocyte glycoprotein antibody are only observed close to clinical events in pediatrics
por: Lui, Allysa, et al.
Publicado: (2021)

Epstein-Barr Virus Glycoprotein Antibody Titers and Risk of Nasopharyngeal Carcinoma
por: Coghill, Anna E, et al.
Publicado: (2022)

Lupus anticoagulant testing during anticoagulation, including direct oral anticoagulants
por: Favaloro, Emmanuel J., et al.
Publicado: (2022)

INTERFERENCE WITH IMMUNE HEMOLYSIS BY GLYCOPROTEIN ANTIGENS
por: Arquilla, E. R., et al.
Publicado: (1964)

Elevated titers of anti-ribosomal-P antibodies in systemic lupus erythematosus
por: Zandman-Goddard, G, et al.
Publicado: (2005)

Interference with the Host Haemostatic System by Schistosomes
por: Mebius, Mirjam M., et al.
Publicado: (2013)

Influence of sample collection tube method, anticoagulant-containing plasma versus serum, on influenza virus hemagglutination inhibition titer and microneutralization titer serological assays
por: Morrison, Brian J., et al.
Publicado: (2018)

A Comparative Analysis of Anticardiolipin, Anti-Β2-Glycoprotein-1, and Lupus Anticoagulants in Saudi Women with Recurrent Spontaneous Abortions
por: Shaikhomar, Osama Abdulrahman, et al.
Publicado: (2022)

Effects and interferences of emicizumab, a humanized bispecific antibody mimicking activated factor VIII cofactor function, on lupus anticoagulant assays
por: Adamkewicz, Joanne I., et al.
Publicado: (2019)

Lupus anticoagulant-hypoprothrombinemia in healthy adult
por: Chung, Choon Hae, et al.
Publicado: (2008)

"Indeterminate lupus anticoagulant" as the third category
por: Park, Sang Hyuk, et al.
Publicado: (2012)

Current Controversies in Lupus Anticoagulant Detection
por: Moore, Gary W.
Publicado: (2016)

The Roles of the Dystrophin-Associated Glycoprotein Complex at the Synapse
por: Pilgram, Gonneke S. K., et al.
Publicado: (2009)

The prevalence of lupus anticoagulant in normal pregnancy and in women with recurrent fetal loss—recommendations for laboratory testing for lupus anticoagulant
por: Al-Mishari, Abdul Aziz A., et al.
Publicado: (2004)

An 89-Year-Old Man with COVID-19-Associated Coagulopathy Presenting with a Prolonged Partial Thromboplastin Time, Lupus Anticoagulant, and a High Titer of Factor VIII Inhibitor
por: Ghafouri, Sanaz, et al.
Publicado: (2020)

Interference of daratumumab with pretransfusion testing, mimicking a high-titer, low avidity like antibody
por: Lin, Mei-Hwa, et al.
Publicado: (2017)

Elevated Antibody Titers to Epstein–Barr Virus and Cytomegalovirus in Patients with Drug-Induced Lupus
por: Knudsen, Julie, et al.
Publicado: (2023)

Anticoagulants Interfere With the Angiogenic and Regenerative Responses Mediated by Platelets
por: Oneto, Paula, et al.
Publicado: (2020)

Antiphospholipid Syndrome Secondary to Lupus Anticoagulant: Case Report for Clinical Anticoagulation Determination
por: Lambroussis, Constantino G, et al.
Publicado: (2022)

Nematode-Induced Interference with Vaccination Efficacy Targets Follicular T Helper Cell Induction and Is Preserved after Termination of Infection
por: Haben, Irma, et al.
Publicado: (2014)

Escaping the catch 22 of lupus anticoagulant testing
por: Vinholt, Pernille Just, et al.
Publicado: (2020)

Diagnostic Challenges on the Laboratory Detection of Lupus Anticoagulant
por: Tripodi, Armando
Publicado: (2021)

Thrombosis and Anticoagulation Therapy in Systemic Lupus Erythematosus
por: Yuan, Wenjun, et al.
Publicado: (2022)

Lupus Anticoagulant Detection under the Magnifying Glass
por: Molinari, Angelo Claudio, et al.
Publicado: (2023)

High titers of antinuclear antibody and the presence of multiple autoantibodies are highly suggestive of systemic lupus erythematosus
por: Li, Hejun, et al.
Publicado: (2022)

Evaluation of different ways to identify persistent positivity of lupus anticoagulant in systemic lupus erythematosus
por: Petri, Michelle A, et al.
Publicado: (2020)

Prothrombin Is Responsible for the Lupus Cofactor Phenomenon in a Patient with Lupus Anticoagulant/Hypoprothrombinemia Syndrome
por: Pengo, Vittorio, et al.
Publicado: (2020)

LUPUS ANTICOAGULANT AND LEG ULCERS IN SICKLE CELL ANEMIA
por: Olayemi, Edeghonghon E, et al.
Publicado: (2009)

Indeterminate lupus anticoagulant results: Prevalence and clinical significance
por: Alkayed, Khaldoun, et al.
Publicado: (2011)

Pulmonary hemorrhage in pediatric lupus anticoagulant hypoprothrombinemia syndrome
por: Kim, Ji Soo, et al.
Publicado: (2014)

Transmission of lupus anticoagulant by allogeneic stem cell transplantation
por: Massoud, Mira Romany, et al.
Publicado: (2014)

A Case of “Refractory” Neuropsychiatric Lupus Responsive to Anticoagulation
por: Wu, Rui, et al.
Publicado: (2017)

Lupus anticoagulant and mortality in patients hospitalized for COVID-19
por: Gazzaruso, Carmine, et al.
Publicado: (2020)

Lupus anticoagulant hypoprothrombinemia syndrome: A case report
por: Acedo, Natalia, et al.
Publicado: (2023)

Successful treatment of lupus anticoagulant hypoprothrombinemia syndrome with rituximab
por: Nusrat, Sanober, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_u34du9v7qtd85hisdeconulas0